시장보고서
상품코드
1268026

미국과 서유럽의 백내장 치료제 시장(2023년) : 지역별 분석(2022-2028년)

2023 US and Western Europe Cataract Pharmaceuticals Market Report - Regional Analysis for 2022-2028

발행일: | 리서치사: Market Scope, LLC | 페이지 정보: 영문 | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

미국과 서유럽의 백내장 치료제 시장에 대해 조사했으며, 시장의 개요와 향후 5년간 시장 성과 예측, 평균 판매 가격, 향후 동향 등을 제공하고 있습니다.

목차

  • 백내장의 이환율과 백내장 수술에 관한 정보
  • 미국과 서유럽 백내장 수술 건수 예측(5년 예측)
  • phakic 렌즈와 굴절교정 렌즈 교환 방법의 논의
  • 백내장 수술에 사용되는 항생제의 판매 예측
  • 백내장 수술에 사용되는 산동약과 모양근 조절약의 판매 예측
  • 백내장 수술에 사용되는 항염증제, 진통제의 판매 예측
  • 미국과 서유럽 백내장 및 백내장/굴절교정 수술 외과의 개요
  • 기업의 수술 프로바이더에 관한 정보
  • 현재의 상환 수준에 관한 논의
  • 개발중인 신제품에 관한 설명
KSA 23.05.18

What's New:

The second-edition "2023 US and Western Europe Cataract Pharmaceuticals Market Report" features new survey data and forecasts for the United States and Western European markets for cataract pharmaceuticals. The new data explore surgeon preferences for preventing infection, dilation, and managing inflammation and pain. The report now provides the market shares of leading competitors, analyzes pharmaceutical use in the United States by providers' surgical volume, and studies the developmental pipeline for drugs and drug delivery.

The "2023 US and Western Europe Cataract Pharmaceuticals Market Report" offers an in-depth examination of the current cataract pharmaceuticals market in the United States and forecasts market performance over the next five years. The report analyzes the current market and forecasts units, average sales price, and revenue through 2028 by product category. It analyzes products currently on the market and examines the development pipeline, discusses the popularity of intracameral injections and fixed combination eye drops, and analyzes the roles of brand name medications, generics, and compounded formulations.

This comprehensive report covers the United States and Western European markets and provides:

  • Information on cataract incidence and cataract surgeries.
  • Current estimates and five-year forecasts for cataract surgery volumes in the United States and Western Europe.
  • Discussion of phakic and refractive lens exchange procedures.
  • Forecasts for sales of antibiotics used in association with cataract surgery.
  • Forecasts for sales of mydriatics and cycloplegics used in cataract surgery.
  • Forecasts for sales of anti-inflammatory drugs and painkillers used in association with cataract surgery.
  • Profile of cataract and cataract/refractive surgeons in the United States and Western Europe
  • Information on corporate surgery providers.
  • Discussion of current reimbursement levels.
  • Descriptions of new products in development.

Author Profile:

Peter Downs

Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of medical industry publications, including the Medical Business Journal, CBS HealthWatch, and Oncology News International.

Prior to joining Market Scope in 2015 and turning his attention to ophthalmology, Peter analyzed markets for organ and tissue transplantation. Since joining Market Scope, he has traveled to several markets outside the US, including China, Europe, and India, to study ophthalmology at the local level.

In addition to his research and writing efforts on the ophthalmic market, he is also a contributor to Ophthalmic Market Perspectives, the firm's monthly industry newsletter.

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제